COMMUNIQUÉS West-GlobeNewswire

Dyadic Develops Stable C1 Cell Lines and Produces Purified Scripps-Designed Bundibugyo Ebola Antigens from Plasmids in Approximately 15 Days
28/07/2026
Delivery of the Bundibugyo viral antigens to Fondazione Biotecnopolo di Siena (“FBS”) and Scripps Research demonstrates C1's potential to accelerate vaccine and monoclonal antibody development, expand platform adoption [...]
Claris Bio Unveils Development Strategy, Planned Pivotal Study Supported by $118 Million Series B Financing from Top-Tier Investors, and Multiple Leadership Appointments
28/07/2026
Positive proof-of-concept clinical data show substantial improvements in visual acuity in limbal stem cell deficiency ( LSCD) patients treated with CSB-001 Pivotal studies for CSB-001 in LSCD planned for 1H 2027 Series [...]
Relmada Therapeutics Appoints Uro-Oncology Leader Bipin Dalmia as Chief Business Officer
28/07/2026
Brings nearly three decades of leadership spanning NMIBC, corporate strategy and business development to help advance NDV-01 and support the Company's long-term growth and value creation. CORAL GABLES, Fla., July 28, [...]
Pacira BioSciences Announces New National Survey Revealing the Hidden Toll of Pain on America’s Workforce
28/07/2026
- Survey findings highlight the prevalence of knee pain, reported impacts on work and quality of life, and strong interest in long-lasting, non-opioid treatment options - BRISBANE, Calif., July 28, 2026 (GLOBE NEWSWIRE [...]
Daré Bioscience Expands Access Options for DARE to PLAY™ and Specialized Menopause Care Through Strategic Collaboration with MyMenopauseRx
28/07/2026
A featured menopause telehealth option is now available to women exploring DARE to PLAY™, advancing Daré’s strategy to build a trusted women’s health ecosystem spanning products, education and access to care [...]
AGC Biologics Lands Commercial Manufacturing Agreement for Yokohama Site Worth Hundreds of Millions of Dollars
28/07/2026
Commercial long-term deal with a large pharmaceutical company pursuing manufacturing and commercial regulatory approvals in major markets Customer commits to AGC Biologics’ new site in Yokohama for five commercial [...]
Greenbrook Opens National Center of Excellence for Advanced Interventional Psychiatry in Rockville, Maryland
28/07/2026
New location expands access to advanced mental health treatments while serving as Greenbrook's flagship innovation center and blueprint for future care delivery MALVERN, Pa., July 28, 2026 (GLOBE NEWSWIRE) -- [...]
Dandy Partners with Yeshiva University's New College of Dental Medicine to Power the Future of Digital Dentistry Education
28/07/2026
The first new dental school in NYC in over a century will run exclusively on Dandy's technology NEW YORK, July 28, 2026 (GLOBE NEWSWIRE) -- Dandy, the fully digital dental lab, today announced a partnership with Yeshiva [...]
Firefly Neuroscience (NASDAQ: AIFF) and Next Health Launch Precision Cognitive Health Initiative as FDA Advisory Committee’s Recommendation Backs Broader Access to Key Neuroprotective Peptides
28/07/2026
– FDA Advisory Committee voted to recommend easing compounding restrictions for six peptides, including Epitalon and Semax, late last week – – These two peptides have attracted growing scientific interest for their [...]
CorVascular Named Exclusive U.S. Importer and Vascular Distributor for ASUS FDA-Cleared Ultrasound Portfolio
28/07/2026
MINNEAPOLIS, July 28, 2026 (GLOBE NEWSWIRE) -- CorVascular today announced its appointment as the exclusive U.S. importer and vascular market distributor for ASUS’s portfolio of FDA-cleared ultrasound devices. [...]
Slate Medicines Establishes Clinical and Scientific Advisory Boards to Advance Next-Generation Migraine Prevention Therapeutics
28/07/2026
Leading neurologists and researchers to provide strategic and clinical guidance as Slate Medicines progresses SLTE-1009 and a broader pipeline of migraine therapeutics. RALEIGH, N.C., July 28, 2026 (GLOBE NEWSWIRE) -- [...]
ProMIS Neurosciences Reports Positive Blinded Six-Month Interim Safety and Biomarker Data for PMN310 in the PRECISE-AD Phase 1b Alzheimer’s Disease Trial
28/07/2026
No ARIA-E observed across all genotypes, including APOE4 homozygotes ARIA-H tracking background rates Early biomarker movement consistent with target engagement 12-month topline results expected in Q1 2027 Cambridge, [...]
Transactions in connection with share buy-back program
28/07/2026
Company announcement no. 27 - 26 28 July 2026 Transactions in connection with share buy-back program On 4 March 2026 NTG Nordic Transport Group (“NTG”) announced a share buy-back program, as described in company [...]
Tensive reports pivotal 12-month clinical trial data confirming REGENERA™ delivers natural breast reconstruction after lumpectomy
28/07/2026
Good-to-excellent cosmetic outcomes 30 of 94 patients enrolled have now reached 24 months of follow-up High surgeon satisfaction sustained through study to date Improvements in patient-reported breast satisfaction and [...]
Aqua free soutient un projet d’accès à l’eau potable en Tanzanie
28/07/2026
Hamburg, 28.07.2026 - Dans de nombreuses régions du monde, l’accès à une eau potable sûre est encore loin d’être garanti. Dans le Lower Moshi, une région située au sud du Kilimandjaro, en Tanzanie, les communautés [...]
Aqua free Supports Drinking Water Project in Tanzania
28/07/2026
Hamburg, 28.07.2026 - Access to safe water is still not given in many parts of the world. In Lower Moshi, a region south of Mount Kilimanjaro in Tanzania, communities and schools struggle with contaminated drinking [...]
Promatix Biosciences Awarded Innovate UK Biomedical Catalyst Grant to Advance First-in-Class EGFR × EphA2 Cis-Bispecific ADC
28/07/2026
Promatix Biosciences Awarded Innovate UK Biomedical Catalyst Grant to Advance First-in-Class EGFR × EphA2 Cis-Bispecific ADC Non-dilutive Biomedical Catalyst funding from Innovate UK will support the advancement of [...]
Xeltis raises an additional €20.5m of funding to advance aXess™ toward FDA approval and US commercial launch
28/07/2026
New investor Horizon 3 Healthcare led the round, which was supported by the European Innovation Council, Invest-NL, VI Partners, EQT Life Sciences, DaVita and other current shareholders Builds on the €50m secured in [...]
Rapid Nutrition Expands Owned-Brand Portfolio Through AI-Driven Commercial Intelligence
28/07/2026
Initial rollout of the Premium Nutrition Pantry demonstrates the Company's strategy to accelerate owned-brand expansion, strengthen vertical integration and support long-term revenue growth LONDON, July 28, 2026 (GLOBE [...]

Pages